Market Tracker

10/24 6:05pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

6.45
Data as of Oct 24
 +0.02 / +0.31%
Today’s Change
4.36
Today|||52-Week Range
8.22
+13.36%
Year-to-Date

Today’s Trading

Previous close6.43
Today’s open6.40
Day’s range6.40 - 6.50
Volume27,549
Average volume (3 months)16,672
Market cap$206.4M
Dividend yield--
Data as of 3:58pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-60.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.10

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...+1.14+11.52%
VCYTVeracyte Inc-0.06-0.74%
DNDNDendreon Corp-0.01-0.96%
OXFDOxford Immunotec Glo...-0.01-0.07%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts